K562 erythroleukemic cells are equipped with multiple mechanisms of resistance to lysis by complement. [electronic resource]
Producer: 20010920Description: 848-54 p. digitalISSN:- 0020-7136
- Antigens, CD -- immunology
- CD55 Antigens -- immunology
- CD59 Antigens -- immunology
- Cell Membrane -- metabolism
- Complement Activation
- Complement System Proteins -- immunology
- Dose-Response Relationship, Drug
- Enzyme Inhibitors -- pharmacology
- Enzyme-Linked Immunosorbent Assay
- Erythrocytes -- metabolism
- Flow Cytometry
- Humans
- K562 Cells
- Leukemia, Erythroblastic, Acute -- immunology
- Membrane Cofactor Protein
- Membrane Glycoproteins -- immunology
- Naphthalenes -- pharmacology
- Neutrophils -- metabolism
- Plant Proteins -- pharmacology
- Protein Kinase C -- metabolism
- Signal Transduction
- Tetradecanoylphorbol Acetate -- pharmacology
- Trypsin Inhibitors
- Tumor Necrosis Factor-alpha -- pharmacology
- alpha-Amylases -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.